LD-2 disclosure · 3rd Quarter - Report
ABBOTT LABORATORIES
Client
- Location
- District of Columbia · United States of America
Registrant
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
6 issuesHealth Issues
S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. H.R. 2369 Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023. Proposals related to sterilization of medical devices. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR). Proposals related to PT/INR (Prothrombin Time/International Normalized Ratio) testing. Proposals related to heart failure technology.
LobbyistsTHOMAS EVERS · AUSTIN BURNES · SETH M RADUS · JENNIFER BARBLAN · ROSALYN KUMAR
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · State, Dept of (DOS) · Environmental Protection Agency (EPA)
Medicare/Medicaid
S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors. Proposals to ensure Medicare coverage for emerging medical device technology. Proposals related to medical device reimbursement and coverage.
LobbyistsTHOMAS EVERS · AUSTIN BURNES · JENNIFER BARBLAN · ROSALYN KUMAR
TargetedSENATE · HOUSE OF REPRESENTATIVES
Trade (domestic/foreign)
Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance. Proposals related to preserving critical medical supply chains.
